According to a recent press release, “Crossix announced today it has added several new data partners and sources as the company continues to expand its network of connected health data. Additional Rx and medical claims data will allow an even more complete picture of the patient journey, including for specialty prescription products. The Crossix analytics platform provides technology that connects health and non-health data for more than 300 million U.S. patients to drive greater marketing effectiveness. Data includes Rx, OTC, clinical, claims, consumer, hospital, media data, and more – all of which are protected by best-in-class privacy safeguards.”
The release continues, “This expanded prescriptions and medical claims data will be integrated into Crossix products and analytics, including into Crossix DIFA, starting in January 2020 across all customers. ‘With our recent integration with Veeva Systems, Crossix plans to accelerate investments in the growth of our data assets to deliver insights that other healthcare data and analytics providers cannot replicate,’ says Asaf Evenhaim, Crossix CEO. ‘This enhanced data footprint will help life sciences companies better understand ever-changing patient dynamics’.”
The release adds, “Crossix partners with top health brands to maximize media and marketing effectiveness through robust data analytics. Fueled by our privacy-by-design, patented Crossix SafeMine™ technology, Crossix connects the industry’s most comprehensive set of health and non-health data, covering more than 300 million lives in the United States. Crossix DIFA™, our best-in-class, cloud-based platform, allows real-time measurement and optimization of complex, cross-channel media campaigns aimed at patients and healthcare professionals.”
Read more at Business Wire.
Image used under license from Shutterstock.com